1. Systemic and tumor level iron regulation in men with colorectal cancer: a case control study
- Author
-
Pusatcioglu, Cenk K, Nemeth, Elizabeta, Fantuzzi, Giamila, Llor, Xavier, Freels, Sally, Tussing-Humphreys, Lisa, Cabay, Robert J, Linzmeier, Rose, Ng, Damond, Clark, Julia, and Braunschweig, Carol
- Subjects
Digestive Diseases ,Nutrition ,Clinical Research ,Cancer ,Colo-Rectal Cancer ,Liver Disease ,Iron metabolism ,Hepcidin ,Inflammation ,Anemia ,Colorectal cancer ,Physiology ,Human Movement and Sports Sciences ,Nutrition and Dietetics ,Nutrition & Dietetics - Abstract
BackgroundIncreased cellular iron exposure is associated with colorectal cancer (CRC) risk. Hepcidin, a liver peptide hormone, acts as the primary regulator of systemic iron status by blocking iron release from enterocytes into plasma. Concentrations are decreased during low iron status and increased during inflammation. The role of hepcidin and the factors influencing its regulation in CRC remains largely unknown. This study explored systemic and tumor level iron regulation in men with CRC.MethodsThe participants were 20 CRC cases and 20 healthy control subjects. Colonic tissue (adenocarcinoma [cases] healthy mucosa [controls]) was subjected to quantitative PCR (hepcidin, iron transporters and IL-6) and Perls' iron staining. Serum was analyzed using ELISA for hepcidin, iron status (sTfR) and inflammatory markers (CRP, IL-6, TNF-α). Anthropometrics, dietary iron intake and medical history were obtained.ResultsCases and controls were similar in demographics, medication use and dietary iron intake. Systemically, cases compared to controls had lower iron status (sTfR: 21.6 vs 11.8 nmol/L, p
- Published
- 2014